Research Paper Volume 9, Issue 3 pp 769—777

Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study

Figure 3. Summary of individualized HbA1c target response (overall and by country). *Patients from Finland were identified by a single investigator. The figure estimates the difference between adjusted means for different factors potentially driving the individualized target setting and thus no reliable statistics for such a low sample size (n=2) could be generated. Hence, Finland has been removed.